Key result
Higher frontal QRS-T angle linked to ~2% higher likelihood of HCM per degree.
Why the study?
The spatial QRS-T angle has shown strong performance for detecting hypertrophic cardiomyopathy but its clinical utility is limited by equipment and computational requirements, prompting evaluation of the more accessible frontal QRS-T angle as a screening tool.
Does the ECG-derived frontal QRS-T angle accurately detect hypertrophic cardiomyopathy in adult screening populations?
Observational (n=3,133)
Does the ECG-derived frontal QRS-T angle accurately detect hypertrophic cardiomyopathy in adult screening populations?
The readily accessible ECG-derived frontal QRS-T angle shows fair to good discriminatory ability and may serve as a practical, noninvasive screening adjunct for hypertrophic cardiomyopathy in adults.
Background Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disorder associated with increased risk of arrhythmias and sudden cardiac death. While the spatial QRS-T angle has shown strong performance for detecting HCM retrospectively, its widespread clinical utility is limited by a need for specific equipment or dense computations. The frontal QRS-T angle can easily be derived from any 12‑lead electrocardiogram (ECG) and may offer a practical screening alternative. Methods We conducted a retrospective analysis of 3133 adults over the age of 30 who participated in the Heartfelt community cardiovascular screening program, including 3124 controls and 9 HCM cases. In the primary analysis, HCM was defined as septal or posterior left ventricular wall thickness ≥15 mm in the absence of hypertension. In a secondary analysis, the definition of HCM was expanded to include patients with hypertension. Frontal QRS-T angle was derived from standard 12‑lead ECGs by calculating the absolute difference between frontal plane QRS axis and the T axis. Receiver operating characteristic (ROC) curve analysis was used to assess the diagnostic performance of frontal QRS-T angle in predicting HCM. In addition, logistic regression was performed to evaluate the association between the frontal QRS-T angle and HCM. Results In the primary analysis, the frontal QRS-T angle demonstrated fair discriminatory ability for HCM detection, with an area under the ROC curve (AUC) of 0.711 (95% CI 0.520–0.901). At a cutoff threshold of 44.5°, sensitivity was 67% and specificity was 86%. In the secondary ROC analysis, which included patients with underlying hypertension in the HCM group, the AUC was 0.806 (95% CI 0.676–0.935). At a threshold of 46.5°, sensitivity was 44% and specificity was 87%. In multivariate logistic regression, frontal QRS-T angle was independently associated with HCM (adjusted OR per 1° increase 1.023; 95% CI 1.008–1.039; p = 0.003). Conclusions The ECG-derived frontal QRS-T angle showed fair to good diagnostic performance as a screening tool for HCM in a healthy adult screening cohort. A higher frontal QRS-T angle was also independently associated with greater odds of HCM in a logistic regressionanalysis. These findings suggest that the QRS-T angle may serve as a useful, noninvasive adjunct for identifying individuals at risk for HCM in broader clinical populations. Further studies with larger and more balanced cohorts are warranted to validate these findings.
No takes yet. Share an insight, caveat, or question.
Grunberg et al. (2026) conducted an observational in Hypertrophic cardiomyopathy (HCM) (n=3,133). Frontal QRS-T angle vs. Lower frontal QRS-T angle was evaluated on Detection of hypertrophic cardiomyopathy (OR 1.023, 95% CI 1.008-1.039, p=0.003). A higher ECG-derived frontal QRS-T angle was independently associated with an increased likelihood of hypertrophic cardiomyopathy (adjusted OR 1.023 per 1° increase; 95% CI 1.008-1.039; p=0.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: